Table 2.
Summary of censored data for outcome variables.
| Variables | Never censored | Ever censored | Total |
|---|---|---|---|
| Participant (N) | |||
| Control group | 59 | 17 | 76 |
| Case group | 69 | 5 | 74 |
| Total | 128 | 22 | 150 |
| Participant (%) | |||
| Control group | 77.63 | 22.37 | 100.00 |
| Case group | 93.24 | 6.76 | 100.00 |
| Total | 85.33 | 14.67 | 100.00 |
| Potential periods of observation (day) | |||
| Control group | 708 | 204 | 912 |
| Case group | 828 | 60 | 888 |
| Total | 1536 | 264 | 1800 |
| Periods with data available (day) | |||
| Control group | 708 | 85 | 793 |
| Case group | 828 | 35 | 863 |
| Total | 1536 | 120 | 1656 |
| Periods with data available (%) | |||
| Control group | 100.00 | 41.67 | 86.95 |
| Case group | 100.00 | 58.33 | 97.18 |
| Total | 100.00 | 45.45 | 92.0 |
| Total percent of the periods with censored data (%) | 0 | 54.55 | 8.00 |
| Total percent of patient numbers censored | 14.67% | ||
| Chi-square distance | P value | ||
| MCAR test result | 48.26 | 0.38 | |
| MCAR (CDM) test result | 102.77 | 1.00 | |
MCAR: missing completely at random; CDM: covariate dependent missingness.